September 19, 2025 · Form 4 insider transaction
Regan Andrew bought 1,120,000 shares of CDT at $0.69 per share, a transaction worth $768.7K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
On September 19, 2025, CDT Equity Inc. (formerly known as Conduit Pharmaceuticals Inc. (the "Issuer")) granted Dr. Andrew Regan ("Dr. Regan") 1,120,000 shares of common stock, par value $0.0001 ("Common Stock"), of the Issuer pursuant to the Issuer's Amended and Restated 2023 Stock Incentive Plan as compensation for his services as a director and an officer of the Issuer.; Based on the closing price per share of Common Stock on September 18, 2025.